About New England IRB

New England IRB is an independent institutional review board for sponsors, CROs and individual researchers across North America. Our priority is to ensure the safety of human subjects in clinical trials, and we are committed to an ethical and thorough review process.

Our Boards are comprised of highly qualified members with significant experience and knowledge in the ethical, scientific and legal aspects of clinical trials.

New England IRB reviews:

• All Phases of FDA regulated clinical trials:

• • Phase I - IV
  • Phase hybrid studies I/IIa      
  • Patient reported outcomes studies
    
  
  

• Drug, device and biologic studies (including vaccine studies)
  

• Registry studies

• Peri-approval and post-approval studies

• Socio-behavioral and educational studies

• Requests for Exemption

Founded in 1988, New England IRB was one of the first central IRBs established to meet the ethical review needs of the clinical trials industry. For studies ranging from one site to several thousand, NEIRB is focused on the protection of human subjects, responsiveness and service.

We offer responsive review timelines while maintaining mechanisms to ensure a thorough, duly diligent, high quality review. Click here for details on our review timelines.

Our secure web portal and electronic systems are helpful tools that create efficiencies in submissions and notifications.

New England IRB has been audited by the United States Food and Drug Administration, and found to be in compliance with regulations. We are qualified to serve as the IRB for federally funded research.

Please contact New England IRB if you would like to arrange for a review. If you need further information, please feel free to call 617-243-3924 or contact us by e-mail.

Top